or Try an Advanced Search...

    Psychiatric Diagnosis Stocks List

    Symbol Grade Name % Change
    ANVS F Annovis Bio, Inc. 6.88
    IKT F Inhibikase Therapeutics, Inc. 21.38
    NLSP F NLS Pharmaceutics Ltd. -3.41
    ALZN F Alzamend Neuro, Inc. 2.50
    PRTA F Prothena Corporation plc 7.50
    RVPH F Reviva Pharmaceuticals Holdings, Inc. -6.66
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Devices
    Related Stock Lists: Alzheimer's Disease Dementia Neurodegeneration Neurological Disorders Parkinson's Disease Aging Associated Diseases Amyloid Biology Lewy Body Dementia Neurodegenerative Disorders Neuroscience Psychiatry Stage Pharmaceutical Adhd Alpha Synuclein Amphetamine Amyloidosis Amyotrophic Lateral Sclerosis Antibodies Attention Deficit Hyperactivity Disorder

    Related ETFs - A few ETFs which own one or more of the above listed Psychiatric Diagnosis stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 26.11
    MEDX D Horizon Kinetics Medical ETF 15.83
    PPH A Market Vectors Pharmaceutical ETF 11.96
    IYH C iShares U.S. Healthcare ETF 11.86
    XLV C SPDR Select Sector Fund - Health Care 11.67
    View all Psychiatric Diagnosis ETFs...
    Compare ETFs
    Compare IHE to IYH Compare IHE to MEDX Compare IHE to PPH

        Psychiatric Diagnosis Stocks Recent News

        Date Stock Title
        May 15 RVPH Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
        May 14 RVPH Reviva Pharmaceuticals GAAP EPS of -$0.25
        May 14 RVPH Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
        May 14 ALZN Alzamend Neuro Announces Initial Closing of Private Placement
        May 14 PRTA News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
        May 13 RVPH Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference
        May 13 ANVS Annovis Bio GAAP EPS of -$0.10 beats by $0.53
        May 13 ANVS Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
        May 12 PRTA Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results
        May 10 ANVS Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
        May 10 ANVS Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
        May 9 ANVS Annovis Bio to post late-stage data for Parkinson's drug in June
        May 9 PRTA Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
        May 9 ANVS Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
        May 9 ALZN Alzamend Neuro enters private placement of up to $25M
        May 9 ALZN EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
        May 9 ALZN Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
        May 9 RVPH Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
        May 9 IKT Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
        May 9 ANVS Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Devices
        Related Stock Lists: Alzheimer's Disease Psychiatry Mental Health Neuroscience Dementia Disorders Medicine Parkinson's Disease Biology Bipolar Disorder Pain Abnormal Psychology Aging Associated Diseases Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Biopharmaceutical Cognitive Disorders Depression Depressive Disorder
        Psychiatric Diagnosis

        Psychiatric diagnosis is the process of determining which mental disorder or disorder a person has, based on a thorough evaluation of the person's symptoms and history. This process typically involves a mental health professional, such as a psychiatrist, psychologist, or clinical social worker, interviewing the person and gathering information from family members, friends, and other sources. The diagnosis is then used to develop a treatment plan that is tailored to the individual's needs.

        Browse All Tags